Mounjaro for Insulin Resistance: Does it Really Work?
Mounjaro (tirzepatide) is gaining attention as a promising treatment for insulin resistance, a condition that affects millions worldwide and is a major precursor to type 2 diabetes. What is Mounjaro? Originally developed as a GLP-1 receptor agonist, Mounjaro also targets glucose-dependent insulinotropic polypeptide (GIP) receptors, making it a dual-action therapy for blood sugar control and […]
